WST West Pharmaceutical Services, Inc.
XNYS 393.48 DelayedStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $223.83 – $396.00
- YTD
- +42.36%
- IV Rank (30D)
- 89.61
- Straddle Price
- $42.20
- P/C Vol Ratio
- 1.74
- Market Cap
- $27.4B
- Open
- $381.98
- Day Range
- $381.98 – $396.00
- Volume
- 573,849
- Prev Close
- $388.78
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.09% |
| Beta vs SPY | 1.02 |
| Cost of Equity (CAPM) | 10.68% (VRP-adj) |
| WACC | 10.74% |
| Volatility Risk Premium | +30.5pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 20.6% |
| Rev. Growth (YoY, DCF input) | +8.4% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.08 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.4B |
| Return on Equity (TTM) | 18.9% |
| Book / Price | 10.6% |
| Gross Margin (TTM) | 36.8% |
| FCF Margin (TTM) | 13.1% |
| Debt / Equity | 0.07 |
| Quality Score | 3/6 — normal (10y DCF) |
| SMA 50 | $359.47 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $373.59 |
| Bollinger Width / SMA20 | 2.0% (drives anchor stability) |
| Net Debt | $-0.2B |
| Market Cap | $28B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $108.07 | 19% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $300.08 | 9% | median 35.4× · 8 peers |
| Peer EV/EBITDA | $347.98 | 9% | median 25.4× · 8 peers |
| Peer P/B | $430.42 | 2% | median 10.4× · 8 peers |
| Peer P/S | $403.10 | 6% | median 8.1× · 8 peers |
| Market Anchor (SMA50) | $359.47 | 38% | stability 100% (BB-width) |
| Options Expected (B-L 30d) | $390.09 | 19% | 27 strikes · skew +0.09 |

- Industry (SIC)
- SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841) · industry map
- Exchange
- XNYS
- Market Cap
- $27.4B
- Employees
- 10,800
- List Date
- 1973-01-02
- CIK
- 0000105770
- Next Earnings
- 2026-10-29 (Pre-Market)
- EPS Forecast
- $2.18 (6 est.)
- Headquarters
- Exton, PA
- Homepage
- https://www.westpharma.com
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximate…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 4.87% | -11.82% | 13.31% | 6.98% | 4.01% | -16.38% | 0.16% |
| Feb | -5.51% | -2.56% | 16.73% | -6.07% | -31.06% | 7.09% | -3.56% |
| Mar | -0.43% | 7.63% | 8.86% | 10.31% | -1.83% | -0.24% | 4.05% |
| Apr | 15.36% | -24.45% | 4.09% | -9.71% | -4.03% | 17.75% | -0.17% |
| May | 5.34% | -0.60% | -8.60% | -8.81% | 0.28% | 7.36% | -0.84% |
| Jun | 5.57% | -2.01% | 11.99% | 0.20% | 4.49% | 13.50% | 5.62% |
| Jul | 13.42% | 11.64% | -2.72% | -5.66% | 7.57% | -6.32% | 2.99% |
| Aug | 8.76% | -12.49% | 9.48% | 3.74% | 3.21% | -1.96% | 1.79% |
| Sep | -6.31% | -16.89% | -7.97% | -1.31% | 7.63% | 9.48% | -2.56% |
| Oct | 2.42% | -10.09% | -14.11% | 2.71% | 3.92% | 7.80%* | -1.22% |
| Nov | 3.73% | 2.25% | 9.04% | 2.90% | -0.90% | -- | 3.40% |
| Dec | 7.72% | -2.76% | 0.09% | 1.52% | 0.36% | -- | 1.39% |
| Total | 67.41% | -50.60% | 40.95% | -5.23% | -12.58% | 38.94% | 13.15% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
Executive Summary
Overall Assessment: NEUTRAL with confidence level (6/10)
Key Drivers:
- Strong recent news sentiment, primarily positive
- Moderate volatility, in line with market expectations
- Bullish MACD signal and rising trend indicators support continued uptrend
Primary Risks:
- Oversold RSI reading, potential for a near-term pullback
- High options market implied volatility, indicating high risk of significant price movements
Investment Thesis: WST's recent performance is driven by positive news sentiment and moderate volatility. The stock has a strong momentum signal in place, but the RSI reading suggests a potential near-term correction.
Recent News Sentiment Impact: Positive news headlines have dominated the narrative, driving investor sentiment higher.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): Bullish, Medium-term (1-3 months): Bullish, Long-term (3-12 months): Bullish
Support/Resistance Levels:
- SMA 20: $278.31
- SMA 50: $258.02
- SMA 200: $259.26
- Upper Bollinger Band: $313.60
- Lower Bollinger Band: $243.01
Momentum Signals:
- RSI (14): 68.24 (neutral)
- MACD signal line crossover above the zero line, indicating bullish momentum
News & Sentiment Analysis
Recent Headlines Summary: Positive news headlines have dominated the narrative, focusing on the company's strong performance and market growth.
Sentiment Assessment: Positive sentiment, driven by recent news articles.
Catalyst Identification: Upcoming earnings release (no specific date available).
Market Narrative: The market is expecting continued growth from WST, driven by positive news sentiment and moderate volatility.
Risk & Volatility Assessment
Beta Interpretation: Beta 0.91 indicates a low to moderate level of risk relative to the broader market.
Volatility Regime: Current vs historical volatility levels: Moderate (42% vs 39.7%).
Options Market Signals:
- IV Rank: 32.2% (Medium)
- Current IV: 90.1%
- Expected Move: $15.60 (13 DTE), 7-DTE: $15.60
- Volume Flow: 57 calls vs 218 puts
- Open Interest: 887 calls vs 3,148 puts
- Put/Call Volume Ratio: 3.83 (Bearish sentiment)
- Market Expectation: Options market pricing $15.60 move by expiration
Market Context & Positioning
Sector Performance: WST is outperforming the sector and broader market.
Institutional Activity: Institutional investors are showing interest in WST, with moderate volume and open interest levels.
Correlation Analysis: WST has a low correlation to the broader market (0.27), indicating a relatively independent trend.
Key Levels & Action Items
Critical Price Levels:
- SMA 20: $278.31
- SMA 50: $258.02
- Upper Bollinger Band: $313.60
Breakout/Breakdown Levels: No specific levels identified, but the upper and lower Bollinger Bands represent key support and resistance levels.
Time-Sensitive Catalysts: Upcoming earnings release (no specific date available).
Risk Management: Stop-loss levels and position sizing considerations will be based on the RSI reading (68.24) and recent volatility levels (0.42).
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-02-18 | Pre-Market | 6.80% | 0.94% | 0.14x | Within |
| 2021-04-29 | Pre-Market | 3.40% | 0.72% | 0.21x | Within |
| 2021-07-29 | Pre-Market | 5.57% | 5.45% | 0.98x | Within |
| 2021-10-28 | Pre-Market | 5.86% | 0.05% | 0.01x | Within |
| 2022-02-17 | Pre-Market | 6.33% | 2.10% | 0.33x | Within |
| 2022-04-28 | Pre-Market | 7.92% | 2.11% | 0.27x | Within |
| 2022-07-28 | Pre-Market | 4.35% | 6.05% | 1.39x | Exceeded |
| 2022-10-27 | Pre-Market | 9.70% | 13.04% | 1.34x | Exceeded |
| 2023-02-16 | Pre-Market | 3.62% | 14.54% | 4.02x | Exceeded |
| 2023-04-27 | Pre-Market | 8.43% | 0.56% | 0.07x | Within |
| 2023-07-27 | Pre-Market | 6.19% | 6.46% | 1.04x | Exceeded |
| 2023-10-26 | Pre-Market | 7.92% | 8.57% | 1.08x | Exceeded |
| 2024-02-15 | Pre-Market | 5.73% | 14.08% | 2.46x | Exceeded |
| 2024-04-25 | Pre-Market | 8.68% | 4.55% | 0.52x | Within |
| 2024-07-25 | Pre-Market | 9.51% | 14.40% | 1.51x | Exceeded |
| 2024-10-24 | Pre-Market | 11.94% | 15.43% | 1.29x | Exceeded |
| 2025-02-13 | Pre-Market | 9.65% | 38.22% | 3.96x | Exceeded |
| 2025-04-24 | Pre-Market | 13.25% | 3.48% | 0.26x | Within |
| 2025-07-24 | Pre-Market | 12.80% | 22.78% | 1.78x | Exceeded |
| 2025-10-23 | Pre-Market | 12.74% | 10.92% | 0.86x | Within |
| 2026-02-12 | Pre-Market | 12.17% | 1.04% | 0.09x | Within |
| 2026-04-23 | Pre-Market | 11.70% | 12.86% | 1.10x | Exceeded |
| 2026-07-23 | Pre-Market | 10.50% | 0.82% | 0.08x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
WST Options Activity & IV Rank
WST IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 79th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Low volatility - stock moves less than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Gates Foundation Trust Foundation Bill Gates | $159.6M | #15 of 24 | 0.0% | 13F | |
| Citadel Hedge fund Ken Griffin | $126.6M | #328 of 6285 | +9.0% | 13F | |
| Point72 Hedge fund Steve Cohen | $101.7M | #170 of 1945 | +77.8% | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $11.1M | #1003 of 3138 | -85.3% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $7.6M | #1780 of 3716 | +54.6% | 13F | |
| Bridgewater Associates Hedge fund Ray Dalio | $3.7M | #537 of 997 | -55.0% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $502K | #2085 of 4729 | -40.6% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
WST Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $27.68M | 37.85% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $13.21M | 18.07% | 2026-06-30 |
| 3 | Jane Street Group, LLC Custodian | $11.49M | 15.71% | 2026-06-30 |
| 4 | PEAK6 LLC | $10.77M | 14.73% | 2026-06-30 |
| 5 | UBS Group AG Custodian | $6.64M | 9.08% | 2026-06-30 |
| 6 | Wolverine Trading, LLC Custodian | $2.11M | 2.88% | 2025-09-30 |
| 7 | Walleye Trading LLC | $789.80K | 1.08% | 2026-06-30 |
| 8 | Bank of Montreal Custodian | $430.80K | 0.59% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Barclays PLC Custodian | $17.95M | 40.68% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $13.93M | 31.57% | 2026-06-30 |
| 3 | Citadel Advisors LLC Custodian | $5.06M | 11.47% | 2026-06-30 |
| 4 | Jane Street Group, LLC Custodian | $2.19M | 4.96% | 2026-06-30 |
| 5 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $835.52K | 1.89% | 2026-09-30 |
| 6 | PEAK6 LLC | $718.00K | 1.63% | 2026-06-30 |
| 7 | Wolverine Trading, LLC Custodian | $676.83K | 1.53% | 2025-09-30 |
| 8 | Point72 Asset Management, L.P. | $574.40K | 1.30% | 2026-06-30 |
| 9 | Millennium Management LLC Custodian | $574.40K | 1.30% | 2026-06-30 |
| 10 | Walleye Trading LLC | $538.50K | 1.22% | 2026-06-30 |
| 11 | TUDOR INVESTMENT CORP ET AL | $430.80K | 0.98% | 2026-06-30 |
| 12 | Bank of Montreal Custodian | $430.80K | 0.98% | 2026-06-30 |
| 13 | Cubist Systematic Strategies, LLC | $209.86K | 0.48% | 2025-09-30 |
WST Insider Trading (Form 4)
Latest: 2026-10-02| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Janet Brutschea Haugen | Director | Award (A) | — | — | EDGAR | |
| 2026-09-15 | Annette F Favorite | Sr. VP & Chief HR Officer | Mixed | — | $222.34 | -$2.00M | EDGAR |
| 2026-09-10 | Annette F Favorite | Sr. VP & Chief HR Officer | Mixed | — | $213.09 | -$2.08M | EDGAR |
| 2026-09-10 | Michel Lagarde | President and CEO | Grant (A) | +51,798 RSU | — | EDGAR | |
| 2026-08-12 | Robert W. McMahon | SVP & Chief Financial Officer | Mixed | +4,040 | $351.37 | -$1.09M | EDGAR |
| 2026-07-01 | Janet Brutschea Haugen | Director | Award (A) | — | — | EDGAR | |
| 2026-05-14 | Shane Alden Campbell | SVP, Proprietary Segment | Mixed | +550 | $312.07 | -$68.4K | EDGAR |
| 2026-05-06 | Mark A Buthman | Director | Award (A) | +791 | — | EDGAR | |
| 2026-05-06 | William F Feehery | Director | Award (A) | +791 | — | EDGAR | |
| 2026-05-06 | Robert F Friel | Director | Award (A) | +791 | — | EDGAR | |
| 2026-05-06 | Janet Brutschea Haugen | Director | Award (A) | +791 | — | EDGAR | |
| 2026-05-06 | Molly Joseph | Director | Award (A) | +791 | — | EDGAR | |
| 2026-05-06 | Deborah L Keller | Director | Award (A) | +791 | — | EDGAR | |
| 2026-05-06 | Goldman Myla Lai | Director | Award (A) | +791 | — | EDGAR | |
| 2026-05-06 | Stephen H Lockhart | Director | Award (A) | +791 | — | EDGAR |
WST Insider Holdings
22 insiders · @ $393.48| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Eric Mark Green | President, CEO and Board Chair | 175,418 | $69.02M | -$137.88M | 53 | 2026-03-03 |
| 2 | Douglas A Michels | Director | 46,495 | $18.30M | $0 | 44 | 2026-05-06 |
| 3 | Thomas W Hofmann | Director | 44,637 | $17.56M | -$1.04M | 23 | 2025-05-08 |
| 4 | Mark A Buthman | Director | 44,308 | $17.43M | $0 | 46 | 2026-05-06 |
| 5 | William F Feehery | Director | 32,519 | $12.80M | $0 | 25 | 2026-05-06 |
| 6 | Annette F Favorite | Sr. VP & Chief HR Officer | 29,284 | $11.52M | -$14.69M | 32 | 2026-09-15 |
| 7 | Goldman Myla Lai | Director | 20,434 | $8.04M | $0 | 25 | 2026-05-06 |
| 8 | Paolo Pucci | Director | 11,854 | $4.66M | $0 | 12 | 2026-05-06 |
| 9 | Deborah L Keller | Director | 11,560 | $4.55M | $0 | 15 | 2026-05-06 |
| 10 | Bernard Birkett | Sr VP, Chief Financial Officer | 7,555 | $2.97M | -$13.11M | 20 | 2025-02-20 |
WST Board & Officers
As of SEC filings through Oct 2, 2026Directors 12
- Thomas W Hofmann · since Oct 16, 2007
- Douglas A Michels · since Feb 22, 2011
- Mark A Buthman · since Feb 22, 2011
- William F Feehery · since Feb 21, 2012
- Goldman Myla Lai · since Feb 18, 2014
- Paolo Pucci · since Sep 12, 2016
- Deborah L Keller · since Jun 1, 2017
- Robert F Friel · on file since Feb 2020
- Molly Joseph · on file since Aug 2021
- Stephen H Lockhart · since Jul 27, 2022
- Janet Brutschea Haugen · since Dec 9, 2024
- Michel Lagarde · since Aug 31, 2026
Officers 8
- Michel Lagarde · President and CEO · since Aug 31, 2026
- Robert W. McMahon · SVP & Chief Financial Officer · since Aug 4, 2025
- Annette F Favorite · Sr. VP & Chief HR Officer · listed since May 2023
- Chad Winters · VP, Chief Accounting Officer · listed since May 2023
- Norman D. Finch Jr. · SVP, GC & Corporate Secretary · since Dec 9, 2025
- Charles Witherspoon · VP & Treasurer · since Mar 21, 2022
- Shane Alden Campbell · SVP, Proprietary Segment · since May 5, 2025
- Rodolphe Jean Poussot · SVP, Strategy & Corporate Dev · since Jul 23, 2025
Changes in the last 10 years (34)
| Aug 31, 2026 | Michel Lagarde became a director |
| Aug 31, 2026 | Michel Lagarde became President and CEO |
| May 31, 2026 | The company announced the departure of Eric Mark Green from the board in an SEC filing |
| Mar 9, 2026 | The company announced the departure of Eric Mark Green as President, CEO and Board Chair in an SEC filing |
| Dec 9, 2025 | Norman D. Finch Jr. became SVP, GC & Corporate Secretary |
| Sep 11, 2025 | The company announced the departure of Kimberly Banks MacKay as SVP, GC & Corporate Secretary in an SEC filing |
| Aug 4, 2025 | Robert W. McMahon became SVP & Chief Financial Officer |
| Jul 23, 2025 | Rodolphe Jean Poussot became SVP, Strategy & Corporate Dev |
| May 5, 2025 | Shane Alden Campbell became SVP, Proprietary Segment |
| Mar 7, 2025 | The company announced the departure of Cindy Reiss-Clark as Chief Commercial Officer in an SEC filing |
| Dec 9, 2024 | Janet Brutschea Haugen became a director |
| Oct 1, 2024 | The company announced the departure of Silji Abraham as SVP, Chief Technology Officer in an SEC filing |
| Dec 8, 2023 | Eric Mark Green listed as President, CEO and Board Chair (previously President & CEO) in SEC filings |
| Aug 24, 2023 | Cindy Reiss-Clark listed as Chief Commercial Officer (previously Senior Vice President) in SEC filings |
| Aug 15, 2023 | Quintin J Lai listed as VP Strat & Investor Relations (previously VP Corp Development & Strategy) in SEC filings |
| Aug 8, 2023 | Bernard Birkett listed as Sr VP, Chief Fin & Ops Off (previously Sr VP, CFO & COO) in SEC filings |
| May 9, 2023 | Chad Winters listed as VP, Chief Accounting Officer (previously VP, CAO & Corporate Controller) in SEC filings |
| May 2, 2023 | Annette F Favorite listed as Sr. VP & Chief HR Officer (previously Sr. VP Human Resources Officer) in SEC filings |
| Mar 22, 2023 | Silji Abraham listed as SVP, Chief Technology Officer (previously Chief Digital & Trans Officer) in SEC filings |
| Jul 27, 2022 | Stephen H Lockhart became a director |
| May 25, 2022 | Bernard Birkett listed as Sr VP, CFO & COO (previously Sr VP, CFO & Treasurer) in SEC filings |
| May 12, 2022 | The company announced the departure of David A Montecalvo as SVP, Glob Ops and Supply Chain in an SEC filing |
| Mar 21, 2022 | Cindy Reiss-Clark became Senior Vice President |
| Mar 21, 2022 | Charles Witherspoon became VP & Treasurer |
| Feb 22, 2022 | The company announced the departure of Patrick J Zenner from the board in an SEC filing |
| Aug 24, 2021 | Molly Joseph first on file as a director |
| Dec 8, 2020 | Kimberly Banks MacKay became SVP, GC & Corporate Secretary |
| May 7, 2020 | Chad Winters listed as VP, CAO & Corporate Controller (previously VP, CAO & Controller) in SEC filings |
| May 5, 2020 | Chad Winters became VP, CAO & Controller |
| Feb 20, 2020 | Robert F Friel first on file as a director |
| Aug 1, 2018 | Quintin J Lai became VP Corp Development & Strategy |
| Jun 21, 2018 | Bernard Birkett became Sr VP, CFO & Treasurer |
| Feb 26, 2018 | Silji Abraham became Chief Digital & Trans Officer |
| Jun 1, 2017 | Deborah L Keller became a director |
- Prev
- 1
Not reported recently (8)
- Bernard Birkett · Last reported as Sr VP, Chief Fin & Ops Off in an SEC filing dated Feb 20, 2025
- Quintin J Lai · Last reported as VP Strat & Investor Relations in an SEC filing dated Feb 22, 2024
- George Lloyd Miller · Last reported as Sr. VP, GC & Corp. Sec. in an SEC filing dated Nov 9, 2020
- Paula A Johnson · Last reported as a director in an SEC filing dated May 7, 2020
- Daniel Malone · Last reported as Vice President & Controller in an SEC filing dated May 1, 2019
- Karen Flynn · Last reported as Sr VP & Chief Commercial Offic in an SEC filing dated Feb 21, 2019
- John H Weiland · Last reported as a director in an SEC filing dated Aug 1, 2018
- William J Federici · Last reported as Sr. VP & CFO in an SEC filing dated Jun 11, 2018
WST Proposed Insider Sales (Form 144)
Latest: 2026-05-07What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | Hofmann Thomas W | Director | 3,384 | $1.09M | 2026-05-07 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2024-08-06 | Green Eric Mark | Officer, Director | 30,732 | $9.36M | 2024-08-06 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2024-05-10 | Hofmann Thomas W | Director | 617 | $225.8K | 2024-05-10 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2024-05-07 | Green Eric Mark | Officer, Director | 66,000 | $24.30M | 2024-05-07 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2024-02-27 | Green Eric Mark | Officer, Director | 64,132 | $23.08M | 2024-02-27 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2023-08-08 | ERIC GREEN | Officer, Director | 44,000 | $17.37M | 2023-08-08 | Morgan Stanley Smith Barney LLC | 10b5-1 | EDGAR |
| 2023-05-09 | ERIC GREEN | Officer, Director | 44,000 | $15.98M | 2023-05-09 | Morgan Stanley Smith Barney LLC | 10b5-1 | EDGAR |
| 2023-05-01 | THOMAS HOFMANN | Director | 1,212 | $443.1K | 2023-05-01 | Morgan Stanley Smith Barney LLC | — | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-06-01 | 0000105770-26-000080 | EDGAR |
| 2026-05-11 | 0000105770-26-000068 | EDGAR |
| 2026-05-05 | 0000105770-26-000056 | EDGAR |
| 2026-04-23 | 0000105770-26-000047 | EDGAR |
| 2026-03-09 | 0000105770-26-000041 | EDGAR |
| 2026-02-12 | 0000105770-26-000005 | EDGAR |
| 2025-10-23 | 0000105770-25-000090 | EDGAR |
| 2025-09-11 | 0000105770-25-000083 | EDGAR |
| 2025-07-24 | 0000105770-25-000062 | EDGAR |
| 2025-07-21 | 0000105770-25-000058 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-02-17 | 0000105770-26-000010 | EDGAR |
| 2025-02-18 | 0000105770-25-000013 | EDGAR |
| 2024-02-20 | 0000105770-24-000015 | EDGAR |
| 2023-02-21 | 0000105770-23-000012 | EDGAR |
| 2022-02-22 | 0001628280-22-003342 | EDGAR |
| 2021-02-23 | 0000105770-21-000008 | EDGAR |
| 2020-02-24 | 0000105770-20-000015 | EDGAR |
| 2019-02-28 | 0000105770-19-000012 | EDGAR |
| 2018-02-26 | 0000105770-18-000006 | EDGAR |
| 2017-02-28 | 0000105770-17-000011 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-04-23 | 0000105770-26-000049 | EDGAR |
| 2025-10-23 | 0000105770-25-000093 | EDGAR |
| 2025-07-24 | 0000105770-25-000065 | EDGAR |
| 2025-04-24 | 0000105770-25-000036 | EDGAR |
| 2024-10-24 | 0000105770-24-000081 | EDGAR |
| 2024-07-25 | 0000105770-24-000066 | EDGAR |
| 2024-04-25 | 0000105770-24-000031 | EDGAR |
| 2023-10-26 | 0000105770-23-000068 | EDGAR |
| 2023-07-27 | 0000105770-23-000048 | EDGAR |
| 2023-04-27 | 0000105770-23-000023 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.04% | $828.2M | — | 2026-09-30 |
| 2 | VOO Vanguard S&P 500 ETF | Vanguard | 0.04% | $684.8M | — | 2026-09-30 |
| 3 | VO Vanguard Morningstar Mid-Cap ETF | Vanguard | 0.26% | $558.7M | — | 2026-09-30 |
| 4 | VUG Vanguard Morningstar Growth ETF | Vanguard | 0.10% | $379.9M | — | 2026-09-30 |
| 5 | IVV iShares Core S&P 500 ETF | iShares (BlackRock) | 0.04% | $363.8M | $890.4B | 2026-10-20 |
| 6 | SPY State Street® SPDR® S&P 500® ETF Trust | SPDR (State Street) | 0.04% | $339.0M | $818.4B | 2026-10-20 |
| 7 | RSP Invesco S&P 500 Equal Weight ETF | Invesco | 0.23% | $226.5M | — | 2026-10-20 |
| 8 | VOT Vanguard Morningstar Mid-Cap Growth ETF | Vanguard | 0.62% | $204.8M | — | 2026-09-30 |
| 9 | XLV State Street® Health Care Select Sector SPDR® ETF | SPDR (State Street) | 0.42% | $199.4M | $47.5B | 2026-10-20 |
| 10 | NOBL ProShares S&P 500 Dividend Aristocrats ETF | ProShares | 1.55% | $179.9M | — | 2026-10-21 |
| 11 | VIG Vanguard Dividend Appreciation ETF | Vanguard | 0.12% | $147.6M | — | 2026-09-30 |
| 12 | IWR iShares Russell Mid-Cap ETF | iShares (BlackRock) | 0.20% | $113.8M | $57.3B | 2026-10-20 |
| 13 | VHT Vanguard Health Care ETF | Vanguard | 0.37% | $80.0M | — | 2026-09-30 |
| 14 | SPYM State Street® SPDR® Portfolio S&P 500® ETF | SPDR (State Street) | 0.04% | $75.5M | $183.5B | 2026-10-20 |
| 15 | IWD iShares Russell 1000 Value ETF | iShares (BlackRock) | 0.07% | $60.8M | $84.5B | 2026-10-20 |
| 16 | SDVY First Trust SMID Cap Rising Dividend Achievers ETF | First Trust | 0.51% | $56.8M | $11.1B | 2026-10-20 |
| 17 | KNG FT Vest S&P 500® Dividend Aristocrats Target Income ETF® | First Trust | 1.53% | $51.4M | $3.4B | 2026-10-20 |
| 18 | SCHG Schwab U.S. Large-Cap Growth ETF | Nport | 0.08% | $49.4M | — | 2026-05-31 |
| 19 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.06% | $48.8M | — | 2026-10-20 |
| 20 | IVE iShares S&P 500 Value ETF | iShares (BlackRock) | 0.09% | $45.5M | $50.4B | 2026-10-20 |
| 21 | IWS iShares Russell Mid-Cap Value ETF | iShares (BlackRock) | 0.27% | $41.4M | $15.6B | 2026-10-20 |
| 22 | QUAL iShares MSCI USA Quality Factor ETF | iShares (BlackRock) | 0.08% | $40.5M | $48.7B | 2026-10-20 |
| 23 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.04% | $35.5M | $97.4B | 2026-10-20 |
| 24 | SPYV State Street® SPDR® Portfolio S&P 500® Value ETF | SPDR (State Street) | 0.09% | $34.6M | $38.3B | 2026-10-20 |
| 25 | TCAF T. Rowe Price Capital Appreciation Equity ETF | Nport | 0.45% | $33.4M | — | 2026-06-30 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $872.30M | $154.00M | $2.15 | $124.00M |
| Q1 '26 | 2026-03-31 | $844.90M | $138.80M | $1.92 | $89.90M |
| Q4 '25 | 2025-12-31 | $805.00M | $132.10M | $1.82 | $251.10M |
| Q3 '25 | 2025-09-30 | $804.60M | $140.00M | $1.92 | $197.20M |
| Q2 '25 | 2025-06-30 | $766.50M | $131.80M | $1.82 | $177.10M |
| Q1 '25 | 2025-03-31 | $698.00M | $89.80M | $1.23 | $129.40M |
| Q4 '24 | 2024-12-31 | $748.80M | $130.10M | $1.78 | $190.10M |
| Q3 '24 | 2024-09-30 | $746.90M | $136.00M | $1.85 | $180.10M |
| Q2 '24 | 2024-06-30 | $702.10M | $111.30M | $1.51 | $165.00M |
| Q1 '24 | 2024-03-31 | $695.40M | $115.30M | $1.55 | $118.20M |
| Q4 '23 | 2023-12-31 | $732.00M | $137.00M | $1.83 | $239.10M |
| Q3 '23 | 2023-09-30 | $747.40M | $161.30M | $2.14 | $230.10M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.